DIAGNOSTIC CHEMORESISTANT MYCOBACTERIUM TUBERCULOSIS IN THE TERNOPIL REGION OF UKRAINE

Author:

Klymnyuk Sergiy I.1,Hryshchuk Leonid A.1,Vynnychuk Mukola O.1,Boiko Tetiana V.1,Smachylo Iryna V.1,Lykhatska Galyna V.1,Smachylo Ivan I.1

Affiliation:

1. I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

Abstract

The aim: To analyze the changes in indicators of tuberculosis mycobacteria sensitivity to anti-mycobacterial drugs over the past nine years in Ternopol region (Ukraine) and to develop recommendations for the use of drug combinations in this region. Materials and methods: The medical examinations were carried out in the Clinical and Diagnostic Laboratory of Ternopil Regional Tuberculosis Hospital during 2007-2017. Sensitivity analysis was carried out on a solid Löwenstein-Jensen medium and in liquid Meedlebrook medium using automatic bacteriological BACTEC 1443 tests with addition to the media of first line anti-TB drugs. Results: The sensitivity of Mycobacterium tuberculosis to anti-TB drugs has decreased in 2017 comparing to 2007, both among new cases and relapses of the disease.During this period in newly diagnosed patients the number of M. tuberculosis sensitive to first-line anti-TB drugs has decreased by 6.1%. Conclusions: Considering the increase in multi-resistant pathogens in newly diagnosed and relapsed of tuberculosis cases, it is necessary to use a modern express methods of diagnostics for the causative agents of tuberculosis and to study their sensitivity to antimycobacterial drugs, especially by using molecular genetics methods.

Publisher

ALUNA

Subject

General Medicine

Reference6 articles.

1. 1. Feshchenko Yu.I., Cheren'ko S.O., Byalyk Y.B. et al. Efektyvnist' statsionarnoho likuvannya khvorykh na khimiorezystentnyy tuberkul'oz na moment zavershennya intensyvnoyi fazy khimioterapiyi [Efficacy of initial phase of chemotherapy in-patiens with the drug resistant tuberculosis]. Ukr. khimioterapevtych. zhurn. 2010;2:33-7. (Ua).

2. 2. Cherenko S.O., Litvinenko N.A, BarbovaІ A.I. et al. Chastota ta profil' medykamentoznoyi rezystentnosti MBT u khvorykh na mul'tyrezystentnyy tuberkul'oz i tuberkul'oz iz rozshyrenoyu rezystentnistyu zalezhno vid vypadku zakhvoryuvannya, kharakteru ta tryvalosti poperedn'oho likuvannya [The frequency and profile of drug resistance of MBT in patients with multidrug-resistant tuberculosis and tuberculosis with expanded resistance depending on the case of the disease, the nature and duration of the preliminary treatment]. Tuberculosis, Lung Diseases, HIV Infection. 2013;2(13):19-25.(Ua).

3. 3. Feshchenko Yu.I., Mel'nyk V.M., Turchenko L.V. et al. Kontseptsiya reformuvannya protytuberkul'oznoyi sluzhby ta optymizatsiya protytuberkul'oznykh zakhodiv v Ukrayini (proyekt) [A concept of reformation of tuberculosis healthcare system and optimization of anti-tuberculosis activity in ukraine (project)]. Ukr. Pulmonol. J. 2015;1:5-9. (Ua).

4. 4. Lepshina S.M. Problemy khimiorezistentnogo tuberkuloza na sovremennom etape [Problems of chemoresistant tuberculosis at the present stage].Archives of clinical and experimental medicine. 2008;1:77-80. (Ru).

5. 5. Lumb R., Bastian I.B., Jelfs P.J. et. al. Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011: A report of the Australian Mycobacterium Reference Laboratory Network. Comm. Dis. Intelligence Quarterly Rep. 2014;38(4):369-75.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3